EMVision Medical Devices Dirección
Dirección controles de criterios 3/4
El CEO de EMVision Medical Devices' es Scott Kirkland , nombrado en Jul 2023, tiene una permanencia de menos de un año. compensación anual total es A$469.42K, compuesta por 54.9% salario y 45.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 5.01% de las acciones de la empresa, por valor de A$9.58M. La antigüedad media del equipo directivo y de la junta directiva es de 2.2 años y 4.8 años, respectivamente.
Información clave
Scott Kirkland
Chief Executive Officer (CEO)
AU$469.4k
Compensación total
| Porcentaje del salario del CEO | 54.9% |
| Permanencia del CEO | less than a year |
| Participación del CEO | 5.0% |
| Permanencia media de la dirección | 2.3yrs |
| Promedio de permanencia en la Junta Directiva | 4.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?
Nov 21
Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation
Apr 24EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment
Nov 09We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth
Jun 17We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jan 07We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jun 08Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation
Feb 22Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%
Dec 20
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth
Nov 24Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$3m |
| Sep 30 2023 | n/a | n/a | -AU$4m |
| Jun 30 2023 | AU$469k | AU$258k | -AU$4m |
| Mar 31 2023 | n/a | n/a | -AU$4m |
| Dec 31 2022 | n/a | n/a | -AU$5m |
| Sep 30 2022 | n/a | n/a | -AU$5m |
| Jun 30 2022 | AU$270k | AU$245k | -AU$6m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | n/a | n/a | -AU$7m |
| Sep 30 2021 | n/a | n/a | -AU$8m |
| Jun 30 2021 | AU$262k | AU$240k | -AU$8m |
| Mar 31 2021 | n/a | n/a | -AU$7m |
| Dec 31 2020 | n/a | n/a | -AU$5m |
| Sep 30 2020 | n/a | n/a | -AU$4m |
| Jun 30 2020 | AU$224k | AU$205k | -AU$3m |
| Mar 31 2020 | n/a | n/a | -AU$3m |
| Dec 31 2019 | n/a | n/a | -AU$3m |
| Sep 30 2019 | n/a | n/a | -AU$3m |
| Jun 30 2019 | AU$213k | AU$150k | -AU$3m |
| Mar 31 2019 | n/a | n/a | -AU$3m |
| Dec 31 2018 | AU$45k | AU$41k | -AU$2m |
Compensación vs. Mercado: La compensación total ($USD302.75K) de Scott está en línea con el promedio de empresas de tamaño similar en el mercado Australian ($USD289.12K).
Compensación vs. Ingresos: La compensación de Scott ha aumentado mientras la empresa no es rentable.
CEO
Scott Kirkland
less than a year
Permanencia
AU$469,419
Compensación
Mr. Scott Kirkland has been an Executive Director of EMvision Medical Devices Limited since July 11, 2017 and serves as its Chief Executive Officer and Managing Director since July 01, 2023. Mr. Kirkland h...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, MD & Executive Director | less than a year | AU$469.42k | 5.01% A$ 9.2m | |
| CFO & Company Secretary | 6.8yrs | sin datos | 1.36% A$ 2.5m | |
| Chief Technology Officer | 1.3yrs | sin datos | sin datos | |
| Chairman of Clinical Advisory Board & Chief Scientific Officer | 3.4yrs | sin datos | 1.22% A$ 2.2m | |
| Head of Design | 3.3yrs | sin datos | sin datos | |
| Head of Tech Development | no data | sin datos | sin datos | |
| Head of Regulatory Affairs | 1.1yrs | sin datos | sin datos |
2.3yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de EMV se considera experimentado (2.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, MD & Executive Director | 6.8yrs | AU$469.42k | 5.01% A$ 9.2m | |
| Chairman of Clinical Advisory Board & Chief Scientific Officer | 4.9yrs | sin datos | 1.22% A$ 2.2m | |
| Ex-Officio Member | 2.2yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 3.7yrs | AU$274.57k | 0.056% A$ 102.1k | |
| Non-Executive Chairman | 6.2yrs | AU$349.37k | 2.42% A$ 4.4m | |
| Non-Executive Director | 6.2yrs | AU$218.18k | 1% A$ 1.8m | |
| Independent Non-Executive Director | 5.9yrs | AU$218.18k | 0.70% A$ 1.3m | |
| Member of Clinical Advisory Board | 4.9yrs | sin datos | sin datos | |
| Member of Clinical Advisory Board | 4.9yrs | sin datos | sin datos | |
| Member of Clinical Advisory Board | 4.9yrs | sin datos | sin datos | |
| Member of Clinical Advisory Board | 4.9yrs | sin datos | sin datos | |
| Ex-Officio Member | 2.2yrs | sin datos | sin datos |
4.9yrs
Permanencia media
Junta con experiencia: La junta directiva de EMV se considera experimentada (4.8 años de antigüedad promedio).